Management Team
William M. Facteau - President and Chief Executive OfficerGeorge A. Harter, Jr. - Chief Financial Officer
Greg S. Garfield - Chief Operating Officer and General Counsel
Mary Bellack - Vice President of Clinical and Regulatory Affairs
Mark A. Bishop - Vice President of Quality
John Y. Chang - Vice President of Research & Development
André K. Cheng, MD, PhD - Medical Director & Vice President of Medical Affairs
Patrick W. Fabian - Senior Vice President WW Sales and Training
Anne-Marie Hodkinson - Vice President of Human Resources
Jeffrey Jones - Vice President of Operations
Karen M. Long - Vice President of Marketing
Greg R. Patterson - Vice President of International Sales
Mr. Facteau has served as the President and Chief Executive Officer and a member of our board of directors since November 2004. From November 1999 to November 2004, Mr. Facteau held a number of sales, marketing and general management positions at Abbott Vascular Devices. Mr. Facteau joined Abbott Laboratories via the acquisition of Perclose, a vessel closure company, where he was the Southeast Regional Sales Manager. From July 1993 to April 1998, Mr. Facteau worked in sales and sales management at United States Surgical Corporation. Mr. Facteau received his B.A. in Political Science from the University of Connecticut.
Mr. Harter has served as the Chief Financial Officer since September 2005. From September 2003 to April 2005, Mr. Harter served as Chief Financial Officer for Velocimed, an interventional cardiology company. From January 2001 to September 2003, Mr. Harter served as Chief Financial Officer of Novare Surgical Systems, an advanced surgical technologies company. From September 1996 to January 2001, Mr. Harter served as Controller of certain divisions within Boston Scientific. Mr. Harter received his B.A. in Economics from the University of California, Los Angeles and his M.B.A. from Case Western Reserve University.
Mr. Garfield has served as the General Counsel since October 2006 and as our Chief Operating Officer and Assistant Secretary since February 2008. From October 2006 to January 2008, Mr. Garfield served as our Vice President of Corporate Development. From April 2006 to October 2006, Mr. Garfield served as Vice President of New Business Development with Boston Scientific’s Cardiovascular Group. From July 1995 to April 2006, Mr. Garfield worked at Guidant, where he most recently served as General Counsel of the Cardiac Surgery Group, and Compass, the corporate investment group. Mr. Garfield received his B.S. in Agricultural Business Management from California Polytechnic State University, San Luis Obispo and his J.D. from the University of the Pacific, McGeorge School of Law.
Ms. Bellack has served as the Vice President, Clinical & Regulatory since July 2009. From June 1990 to December 2007 she held a variety of senior general management roles in several of Guidant’s divisions in marketing, international, business development and clinical/regulatory/quality. Prior to joining Guidant she worked for The Boston Consulting Group and E.F. Hutton & Co. Ms. Bellack received her B.A. in computer science and economics from Brandeis University and a M.B.A. from Stanford.
Mr. Bishop has served as the Vice President of Quality since June 2006. From February 2005 to June 2006, Mr. Bishop served as our Director of Operations. From November 1999 to February 2005, Mr. Bishop worked with Abbott Vascular Devices as Director of Engineering. From January 1996 to November 1999, Mr. Bishop held various management positions at Perclose, which was later acquired by Abbott Laboratories. From March 1992 to January 1996, Mr. Bishop worked with Devices for Vascular Intervention, which was acquired by Eli Lilly & Co. and subsequently merged into Guidant. Mr. Bishop received his B.S. in Mechanical Engineering Technology from California Polytechnic State University, San Luis Obispo.
Mr. Chang has served as the Vice President of Research and Development since June 2004. From March 2004 to June 2004, Mr. Chang co-founded Acclarent while working for ExploraMed II as Project Architect of Engineering. From September 1997 to January 2004, Mr. Chang served as a Program Manager of Engineering at TransVascular, a developer of catheter-based percutaneous bypass procedures and drug delivery. From September 1992 to September 1997, Mr. Chang held various positions at General Surgical Innovations (Tyco) and Guidant. Mr. Chang received his B.S. in Mechanical and Aerospace Engineering from Princeton University and his M.S. in Mechanical Engineering from Stanford University.
Dr. Cheng has served as the Medical Director and Vice President of Medical Affairs since April 2007 and Vice President of Medical Affairs and Reimbursement since February 2008. From July 2001 to April 2007, Dr. Cheng was with The Advisory Board Company, where he served as Managing Partner of the Medical Technology Solutions division and Executive Director of the Syndicated Research division. From January 2003 to April 2007, Dr. Cheng launched and managed the Innovations Center, a strategic forecasting program, and Technology Insights, an on-demand technology assessment service. From June 1999 to April 2007, Dr. Cheng has published articles in peer-reviewed journals including JAMA, served as an editor and reviewer for several leading medical journals, and authored Advisory Board publications on healthcare business strategy. Dr. Cheng received his A.B. in Biochemical Sciences from Harvard College, his M.D. from The Johns Hopkins School of Medicine and his Ph.D. in Clinical Investigation and Health Economics from The Johns Hopkins Schools of Medicine and Public Health.
Mr. Fabian has served as the Vice President of U.S. Sales and Training since August 2007. From November 2004 to August 2007, Mr. Fabian worked at Accellent, where he most recently served as Senior Vice President of Sales and Marketing. From September 2001 to November 2004, Mr. Fabian served as Director of Sales for Smith & Nephew’s Endoscopy division. Mr. Fabian received his B.A. in Business Administration from the University of St. Thomas.
Ms. Hodkinson has served as the Vice President of Human Resources since April, 2009. From June 2007 to April 2009, Ms. Hodkinson was the Vice President of Human Resources at XTENT, a Foundry company focusing on the development of customizable drug-eluting stent (DES) systems for the treatment of coronary artery disease. From March 2006 to June 2007, Ms. Hodkinson served as Director of Human Resources at Cytyc Corporation, acquired by Hologic, Inc. From October 1999 to March 2006, Ms. Hodkinson held the position of Director of Human Resources at Medtronic a medical technology company. Ms. Hodkinson holds a B.S. in Business Administration from California State Polytechnic University, Pomona and an M.A. in Human Resources and Organizational Development from the University of San Francisco.
Mr. Jones has served as Vice President of Operations since September 2009. From January 2009 to August 2009, Mr. Jones served as Chief Operating Officer for Polyremedy, an advanced wound care company. From May 2004 to December 2008, Mr. Jones served as Chief Operating Officer for Reliant Technologies, an aesthetic laser company. From February 2001 to February 2004, Mr. Jones served as Chief Operating Officer at Lumend, an interventional cardiology company. From March 1996 to February 2001, Mr. Jones served as Vice President of Operations of certain divisions within Boston Scientific. Mr. Jones received a B.S. in Engineering from West Point and his MBA from Golden Gate University.
Ms. Long has served as the Vice President of Marketing since March 2007. From November 2001 to March 2007, Ms. Long served as Director of Global Strategic Marketing and Director of New Product Development for Lifescan, a division of Johnson & Johnson. From April 2000 to November 2001, Ms. Long served as Director of Clinical and Business Services at Inverness Medical Technologies, which was acquired by Johnson & Johnson. Prior to Inverness Medical, Ms. Long held management positions at ChemTrak, Inc and HCA Healthcare. Ms. Long received her B.S. and M.S. from San Diego State University.
Mr. Patterson joined Acclarent in July of 2009 as Vice President of International Sales. From 2004 to 2008 Mr. Patterson served as President/CEO of obesity space front runner Satiety, Inc. Between 2001 and 2004 Mr. Patterson’s served as turnaround specialist and President of Novare Surgical. From 1996 until 2001, Mr. Patterson co-founded Prolifix Medical, an innovative atherectomy company. Mr. Patterson earned his B.A. from the University of Illinois.


